Timothy Brennan
Biopredic (France)(FR)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Bladder and Urothelial Cancer Treatments, Epigenetics and DNA Methylation, Acute Myeloid Leukemia Research, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer(2015)536 cited
- → Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting(2016)302 cited
- → Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity(2014)279 cited
- → Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors(2013)214 cited
- → Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA(2018)195 cited
- → A network biology approach to prostate cancer(2007)162 cited
- → Pyogenic Infection of the Sacroiliac Joint Case Reports and Review of the Literature(1991)123 cited
- → Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias(2016)66 cited
- → Abstract 1118: Activation of MET via diverse exon 14 skipping mutations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors(2015)10 cited
- → Defects in DNA repair genes and sensitivity to cisplatin based neoadjuvant chemotherapy (NAC) for bladder cancer.(2015)10 cited